If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ACTRAPID human insulin (rys) 100IU/mL injection multidose vial AUST R: 169625Active ingredients:
insulin
Dosage form:
Injection, solution
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800 668 626
|
From
20 Dec 2024
to
31 Jan 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
The sponsor is working to expedite the next shipment. An alternative presentation is available.
|
ACTRAPID PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169623Active ingredients:
insulin
Dosage form:
Injection, solution
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800 668 626
|
Deletion from market:
31 Dec 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available.
|
MIXTARD 30/70 INNOLET human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169628Active ingredients:
insulin
Dosage form:
Injection, suspension
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800 668 626
|
Deletion from market:
31 Jul 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
|
MIXTARD 30/70 PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169629Active ingredients:
insulin
Dosage form:
Injection, suspension
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800 668 626
|
Deletion from market:
02 Oct 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative products are available
|
PROTAPHANE INNOLET human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169633Active ingredients:
insulin
Dosage form:
Injection, suspension
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800 668 626
|
Deletion from market:
01 Feb 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available.
|
PROTAPHANE PENFILL human insulin (rys) 100IU/mL injection multidose cartridge AUST R: 169635Active ingredients:
insulin
Dosage form:
Injection, suspension
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800 668 626
|
Deletion from market:
31 Dec 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available.
|